Cargando…

Neutralisation of SARS-CoV-2 by monoclonal antibody through dual targeting powder formulation

Neutralising monoclonal antibody (mAb) is an important weapon in our arsenal for combating respiratory viral infections. However, the effectiveness of neutralising mAb has been impeded by the rapid emergence of mutant variants. Early administration of broad-spectrum mAb with improved delivery effici...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seow, Han Cong, Cai, Jian-Piao, Pan, Harry Weijie, Luo, Cuiting, Wen, Kun, Situ, Jianwen, Wang, Kun, Cao, Hehe, Leung, Susan W.S., Yuan, Shuofeng, Lam, Jenny K.W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier B.V. 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148961/ https://www.ncbi.nlm.nih.gov/pubmed/37084889 http://dx.doi.org/10.1016/j.jconrel.2023.04.029

Ejemplares similares

Dual targeting powder formulation of antiviral agent for customizable nasal and lung deposition profile through single intranasal administration
por: Seow, Han Cong, et al.
Publicado: (2022)

Broad-spectrum humanized monoclonal neutralizing antibody against SARS-CoV-2 variants, including the Omicron variant
por: Wen, Kun, et al.
Publicado: (2023)

Development and characterisation of neutralising monoclonal antibody to the SARS-coronavirus
por: Berry, Jody D, et al.
Publicado: (2004)

Spray-Dried Powder Formulation of Capreomycin Designed for Inhaled Tuberculosis Therapy
por: Shao, Zitong, et al.
Publicado: (2021)

Humanised monoclonal antibodies neutralise pertussis toxin by receptor blockade and reduced retrograde trafficking
por: Acquaye‐Seedah, Edith, et al.
Publicado: (2018)

Neutralisation sensitivity of SARS-CoV-2 omicron subvariants to therapeutic monoclonal antibodies
por: Yamasoba, Daichi, et al.
Publicado: (2022)

Co-Delivery of D-LAK Antimicrobial Peptide and Capreomycin as Inhaled Powder Formulation to Combat Drug-Resistant Tuberculosis
por: Shao, Zitong, et al.
Publicado: (2023)

Neutralisation and the brickwall
por: Hereward, H G
Publicado: (1974)

Virus Neutralisation: New Insights from Kinetic Neutralisation Curves
por: Magnus, Carsten
Publicado: (2013)

Engineering, Expression in Transgenic Plants and Characterisation of E559, a Rabies Virus-Neutralising Monoclonal Antibody
por: van Dolleweerd, Craig J., et al.
Publicado: (2014)

EE315 Economic Evaluation of Neutralising Monoclonal Antibodies for the Treatment of COVID-19 Positive People in the Community
por: Metry, A, et al.
Publicado: (2022)

Comparative evaluation and longevity of neutralising and binding antibodies for SARS-COV-2
por: Davidson, Natalie, et al.
Publicado: (2021)

Sindbis virus neutralising antibodies detected in Swedish horses
por: Björnström, Agnes, et al.
Publicado: (2021)

Epitopes recognised by neutralising and non-neutralising anti-envelope antibodies define surface exposed regions of HTLV-1 envelope
por: Brighty, David W, et al.
Publicado: (2014)

Inhalable Protein Powder Prepared by Spray-Freeze-Drying Using Hydroxypropyl-β-Cyclodextrin as Excipient
por: Lo, Jason C. K., et al.
Publicado: (2021)

Characterisation of a highly potent and near pan-neutralising anti-HIV monoclonal antibody expressed in tobacco plants
por: Moore, Catherine M., et al.
Publicado: (2021)

Spray freeze drying of small nucleic acids as inhaled powder for pulmonary delivery
por: Liang, Wanling, et al.
Publicado: (2018)

Development of Stable Influenza Vaccine Powder Formulations: Challenges and Possibilities
por: Amorij, J-P., et al.
Publicado: (2008)

Neutralisation pockets and spectral lines
por: Gröbner, Oswald
Publicado: (1972)

On Toxic Neutralisations: II. Reconstitution
por: Richardson, Benjamin Ward
Publicado: (1894)

Mechanisms of Rhinovirus Neutralisation by Antibodies
por: Touabi, Lila, et al.
Publicado: (2021)

Insensitivity of Paediatric HIV-1 Subtype C Viruses to Broadly Neutralising Monoclonal Antibodies Raised against Subtype B
por: Gray, Elin Solomonovna, et al.
Publicado: (2006)

Endothelial eNAMPT amplifies pre-clinical acute lung injury: efficacy of an eNAMPT-neutralising monoclonal antibody
por: Quijada, Hector, et al.
Publicado: (2021)

Comparative effectiveness of neutralising monoclonal antibodies in high risk COVID-19 patients: a Bayesian network meta-analysis
por: McConnell, David, et al.
Publicado: (2022)

Characterization and Formulation of Isoniazid for High-Dose Dry Powder Inhalation
por: Sibum, Imco, et al.
Publicado: (2019)

Filovirus Neutralising Antibodies: Mechanisms of Action and Therapeutic Application
por: Hargreaves, Alexander, et al.
Publicado: (2021)

FORMULATION AND EVALUATION OF POLYHERBAL HAIR CARE POWDERS
por: Azam, Afzal, et al.
Publicado: (1996)

Neutralising Antibodies against Ricin Toxin
por: Prigent, Julie, et al.
Publicado: (2011)

Electron cooling with neutralised electron beams
por: Bosser, Jacques, et al.
Publicado: (1994)

Electron cooling with neutralised electron beams
por: Bosser, J, et al.
Publicado: (1994)

On Toxic Neutralisations: I.—Isomeric Variation
por: Richardson, Benjamin Ward
Publicado: (1894)

Intranasal Boosting with Spike Fc-RBD of Wild-Type SARS-CoV-2 Induces Neutralizing Antibodies against Omicron Subvariants and Reduces Viral Load in the Nasal Turbinate of Mice
por: Cai, Jian-Piao, et al.
Publicado: (2023)

Neutralisation of uPA with a Monoclonal Antibody Reduces Plasmin Formation and Delays Skin Wound Healing in tPA-Deficient Mice
por: Jögi, Annika, et al.
Publicado: (2010)

Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies
por: Wilhelm, Alexander, et al.
Publicado: (2022)

Glycan masking of a non-neutralising epitope enhances neutralising antibodies targeting the RBD of SARS-CoV-2 and its variants
por: Carnell, George W., et al.
Publicado: (2023)

Antioxidant Potential of Cookies Formulated with Date Seed Powder
por: Najjar, Zein, et al.
Publicado: (2022)

Radiolabeling Method for Lyophilizate for Dry Powder Inhalation Formulations
por: Miyamoto, Kahori, et al.
Publicado: (2022)

The Influence of Formulation Components and Environmental Humidity on Spray-Dried Phage Powders for Treatment of Respiratory Infections Caused by Acinetobacter baumannii
por: Yan, Wei, et al.
Publicado: (2021)

Nasal Powder Formulations: In-Vitro Characterisation of the Impact of Powders on Nasal Residence Time and Sensory Effects
por: Trenkel, Marie, et al.
Publicado: (2021)

Neutralisation of accelerator beams by ionisation of the residual gas
por: Baconnier, Yves, et al.
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_dbho3jp630vve4884tlnbthua9